Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
110 milligram (mg) fampridine-SR (4-aminopyridine, 4-AP)----[1] 13 💬
215 mg fampridine-SR (4-aminopyridine, 4-AP)----[1] 13 💬
320 mg fampridine-SR (4-aminopyridine, 4-AP)----[1] 13 💬
44-aminopyridine----[2] 3, 13 💬
5Dalfampridine
(4-Aminopyridine)
[1] Dalfampridine (4-Aminopyridine)[1] Dalfampridine (4-Aminopyridine) 💬 [7] KCNA1,
KCNA2,
KCNA4,
KCNA6,
KCNC3,
KCND2,
KCND3 💬
[5] Cortisol synthesis and secretion, Cushing syndrome, IgSF CAM signaling, Serotonergic synapse, Spinocerebellar ataxia 💬[2] 4, 13 💬
6Dalfampridine 10 MG [Ampyra]
(4-Aminopyridine)
[1] Dalfampridine (4-Aminopyridine)[1] Dalfampridine (4-Aminopyridine) 💬 [7] KCNA1,
KCNA2,
KCNA4,
KCNA6,
KCNC3,
KCND2,
KCND3 💬
[5] Cortisol synthesis and secretion, Cushing syndrome, IgSF CAM signaling, Serotonergic synapse, Spinocerebellar ataxia 💬[1] 13 💬
7Dalfampridine ER
(4-Aminopyridine)
[1] Dalfampridine (4-Aminopyridine)[1] Dalfampridine (4-Aminopyridine) 💬 [7] KCNA1,
KCNA2,
KCNA4,
KCNA6,
KCNC3,
KCND2,
KCND3 💬
[5] Cortisol synthesis and secretion, Cushing syndrome, IgSF CAM signaling, Serotonergic synapse, Spinocerebellar ataxia 💬[1] 13 💬
8Dalfampridine ER, 10 Mg Oral Tablet, Extended Release
(4-Aminopyridine)
[1] Dalfampridine (4-Aminopyridine)[1] Dalfampridine (4-Aminopyridine) 💬 [7] KCNA1,
KCNA2,
KCNA4,
KCNA6,
KCNC3,
KCND2,
KCND3 💬
[5] Cortisol synthesis and secretion, Cushing syndrome, IgSF CAM signaling, Serotonergic synapse, Spinocerebellar ataxia 💬[1] 13 💬
9Dalfampridine-ER 10mg
(4-Aminopyridine)
[1] Dalfampridine (4-Aminopyridine)[1] Dalfampridine (4-Aminopyridine) 💬 [7] KCNA1,
KCNA2,
KCNA4,
KCNA6,
KCNC3,
KCND2,
KCND3 💬
[5] Cortisol synthesis and secretion, Cushing syndrome, IgSF CAM signaling, Serotonergic synapse, Spinocerebellar ataxia 💬[1] 13 💬
10Dalfampridine-ER 5mg
(4-Aminopyridine)
[1] Dalfampridine (4-Aminopyridine)[1] Dalfampridine (4-Aminopyridine) 💬 [7] KCNA1,
KCNA2,
KCNA4,
KCNA6,
KCNC3,
KCND2,
KCND3 💬
[5] Cortisol synthesis and secretion, Cushing syndrome, IgSF CAM signaling, Serotonergic synapse, Spinocerebellar ataxia 💬[1] 13 💬
11Other: Dalfampridine plus physical therapy
(4-Aminopyridine)
[1] Dalfampridine (4-Aminopyridine)[1] Dalfampridine (4-Aminopyridine) 💬 [7] KCNA1,
KCNA2,
KCNA4,
KCNA6,
KCNC3,
KCND2,
KCND3 💬
[5] Cortisol synthesis and secretion, Cushing syndrome, IgSF CAM signaling, Serotonergic synapse, Spinocerebellar ataxia 💬[1] 13 💬
12Other: Withdrawal of dalfampridine-ER 10mg
(4-Aminopyridine)
[1] Dalfampridine (4-Aminopyridine)[1] Dalfampridine (4-Aminopyridine) 💬 [7] KCNA1,
KCNA2,
KCNA4,
KCNA6,
KCNC3,
KCND2,
KCND3 💬
[5] Cortisol synthesis and secretion, Cushing syndrome, IgSF CAM signaling, Serotonergic synapse, Spinocerebellar ataxia 💬[1] 13 💬
13Sustained-release oral dalfampridine
(4-Aminopyridine)
[1] Dalfampridine (4-Aminopyridine)[1] Dalfampridine (4-Aminopyridine) 💬 [7] KCNA1,
KCNA2,
KCNA4,
KCNA6,
KCNC3,
KCND2,
KCND3 💬
[5] Cortisol synthesis and secretion, Cushing syndrome, IgSF CAM signaling, Serotonergic synapse, Spinocerebellar ataxia 💬[1] 13 💬